And what really frustrates people is that GLP-1 is something the body already makes, but companies tweak it just enough to patent it and then act like they own it ***Theres no reason one company should control a natural hormone just because they made a small modification
So before you jump into any new eating strategy, do the smart thing: get a thumbs-up from your doctor
However, it is important to note that these findings are preliminary, and comprehensive, targeted clinical trials focusing specifically on IBS populations are required to fully understand the efficacy and safety of Semaglutide in this context
placebo in mild Alzheimer's) What this trial does not yet establish: Whether GLP-1 drugs prevent dementia that is the question the trial is designed to answer
desensitization is unclear if used beyond saturation dose
Semaglutide has been associated with reduction in liver fat and inflammation, potentially reversing certain types of liver damage